Nutritional Status of Infants and Children with Eczematous Dermatitis

Insights

Eczematous dermatitis in children is linked to significant nutritional failure and malnutrition. Associated pyogenic infections appear to be the primary driver of malnutrition in these cases.

Area of Science:

  • Pediatrics
  • Dermatology
  • Nutrition Science

Background:

  • Eczematous dermatitis is a common condition in infants and children.
  • Nutritional status is crucial for child development and immune function.
  • The relationship between skin conditions and malnutrition requires further investigation.

Purpose of the Study:

  • To investigate the prevalence of nutritional failure in children with eczematous dermatitis.
  • To explore the potential role of eczematous dermatitis in causing malnutrition.
  • To identify factors contributing to malnutrition in this pediatric population.

Main Methods:

  • Study included 70 infants and children (1 month to 5 years) with various types of eczematous dermatitis.
  • Nutritional status was assessed anthropometrically and biochemically (serum proteins, albumin).
  • Children were categorized based on malnutrition type (acute/chronic) and socioeconomic status.

Main Results:

  • 83% of children exhibited nutritional failure, with 23% acute and 60% chronic malnutrition.
  • Low serum proteins, particularly albumin, were observed in children with eczema.
  • Despite better socioeconomic conditions in some, malnutrition persisted, suggesting a link to dermatitis.

Conclusions:

  • Eczematous dermatitis is associated with significant nutritional deficits in children.
  • Pyogenic infections complicating eczema are strongly implicated as a cause of malnutrition.
  • Early identification and management of both dermatitis and malnutrition are essential.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
990
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
89.0K